You can buy or sell Biodesix and other stocks, options, and ETFs commission-free!
Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. The firm offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer.
52 Week High
52 Week Low
— per share
Expected May 6, After Hours